December 13, 2022: BFM Business interview of Hervé Affagard - Good Morning Business - MaaT Pharma

(French only)

To see the interview, click here!

Previous PostDecember 13, 2022: BSmart interview of Hervé Affagard – Smart Tech (French only)
Next PostRestoration of gut microbiota diversity with oral pooled fecal microbiotherapy in acute myeloid leukemia patients after intensive chemotherapy: the phase 1b CIMON trial

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club